The results of the infection per patient analysis and the infection rate per patient-month analysis
| Infection type . | Product . | Pooled infection rate per patient . | P value . | Pooled infection rate per patient-month . | P value . |
|---|---|---|---|---|---|
| All-grade infections | CAR T | 0.44 | .18 | 0.0167 | .0012∗ |
| CD28 CAR T | 0.52 | .77 | 0.0182 | .006∗ | |
| 4-1BB CAR T | 0.34 | .02∗ | 0.0144 | .02∗ | |
| BsAbs | 0.54 | — | 0.0397 | — | |
| Grade 3+ infections | CAR T | 0.16 | .08 | 0.0069 | .0003∗ |
| CD28 CAR T | 0.22 | .98 | 0.0076 | .01∗ | |
| 4-1BB CAR T | 0.13 | .003∗ | 0.0064 | .0002∗ | |
| BsAbs | 0.22 | — | 0.0165 | — | |
| Infection-related mortality | CAR T | 0.04 | .26 | 0.0023 | .89 |
| CD28 CAR T | 0.07 | .01∗ | 0.0024 | .89 | |
| 4-1BB CAR T | 0.03 | .76 | 0.0023 | .96 | |
| BsAbs | 0.03 | — | 0.0022 | — |
| Infection type . | Product . | Pooled infection rate per patient . | P value . | Pooled infection rate per patient-month . | P value . |
|---|---|---|---|---|---|
| All-grade infections | CAR T | 0.44 | .18 | 0.0167 | .0012∗ |
| CD28 CAR T | 0.52 | .77 | 0.0182 | .006∗ | |
| 4-1BB CAR T | 0.34 | .02∗ | 0.0144 | .02∗ | |
| BsAbs | 0.54 | — | 0.0397 | — | |
| Grade 3+ infections | CAR T | 0.16 | .08 | 0.0069 | .0003∗ |
| CD28 CAR T | 0.22 | .98 | 0.0076 | .01∗ | |
| 4-1BB CAR T | 0.13 | .003∗ | 0.0064 | .0002∗ | |
| BsAbs | 0.22 | — | 0.0165 | — | |
| Infection-related mortality | CAR T | 0.04 | .26 | 0.0023 | .89 |
| CD28 CAR T | 0.07 | .01∗ | 0.0024 | .89 | |
| 4-1BB CAR T | 0.03 | .76 | 0.0023 | .96 | |
| BsAbs | 0.03 | — | 0.0022 | — |
The P values are taken from the subgroup analyses described in the text comparing all CAR T, CD28-based CAR T, and 4-1BB–based CAR T with BsAbs.
Boldface values are statistically significant.